Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price target lifted by Mizuho from $145.00 to $179.00 in a research report sent to investors on Friday morning, Benzinga reports. Mizuho currently has a buy rating on the biotechnology company’s stock. SRPT has been the topic of several other research reports. UBS Group raised their price […]
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) shot up 5.9% during mid-day trading on Wednesday . The stock traded as high as $124.37 and last traded at $124.01. 550,813 shares traded hands during trading, a decline of 43% from the average session volume of 972,684 shares. The stock had previously closed at […]
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Stock analysts at William Blair reduced their FY2024 EPS estimates for Sarepta Therapeutics in a research report issued on Wednesday, April 17th. William Blair analyst T. Lugo now forecasts that the biotechnology company will post earnings per share of $6.66 for the year, down from their previous […]
Peregrine Capital Management LLC Trims Stock Position in Sarepta Therapeutics, Inc (NASDAQ:SRPT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has earned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month target price […]